Log In
Print
BCIQ
Print
Print this Print this
 

N91115

  Manage Alerts
Collapse Summary General Information
Company N30 Pharmaceuticals LLC
DescriptionOral s-nitrosoglutathione reductase inhibitor
Molecular Target Alcohol dehydrogenase 5 (ADH5) (GSNOR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today